Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Business Today.
Press releases published on April 30, 2025
Information relative au nombre total de droits de vote et d’actions composant le capital social au 11 avril 2025
GlobeNewswire
·
April 30, 2025
Article R. 22-10-23 du Code de commerce Place de cotation : Euronext Paris Code ISIN / Mnémo : FR0013233012 / IVA Site web : www.inventivapharma.com Date Nombre de titres composant le capital en circulation Nombre total de droits de vote bruts(1) …
Statement of total voting rights and shares forming the company’s share capital as of April 11, 2025
GlobeNewswire
·
April 30, 2025
Article R. 22-10-23 of the French Commercial Code Market: Euronext Paris ISIN code / Mnemo: FR0013233012 / IVA Web site: www.inventivapharma.com Date Number of shares outstanding Total voting rights, gross (1) Total voting rights, net (2) April 11, 2025 95 …
Combined General Meeting of May 22, 2025 - Availability of the preparatory documents
GlobeNewswire
·
April 30, 2025
Daix (France), New York City (New York, United States), April 30, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic …
Assemblée Générale Mixte du 22 mai 2025 - Modalités de mise à disposition des documents préparatoires
GlobeNewswire
·
April 30, 2025
Daix (France), New York City (New York, Etats-Unis), le 30 avril 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …
DBV Technologies Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
Châtillon, France, April 30, 2025 DBV Technologies Reports First Quarter 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today …
DBV Technologies publie ses résultats financiers du 1er trimestre 2025
GlobeNewswire
·
April 30, 2025
Châtillon, France, le 30 avril (22 :00 CEST) 2025 DBV Technologies publie ses résultats financiers du 1er trimestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP :23306J309), société biopharmaceutique au …
TBBK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Bancorp, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
APP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AppLovin Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
ELF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that e.l.f. Beauty, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
RC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ready Capital Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …
Warp Launches “FreedomChain” to Help U.S. Brands Modernize the One Part of Their Supply Chain They Can Actually Control
GlobeNewswire
·
April 30, 2025
Los Angeles, CA, April 30, 2025 (GLOBE NEWSWIRE) -- Warp, the tech-driven middle-mile logistics leader, has launched FreedomChain, a new program built to help brands and retailers optimize the one part of their supply chain they can still control: the …
OTC Markets Group Announces First Quarter 2025 Earnings Conference Call and Webcast
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM) today announced it will report its financial results for the first quarter ended March 31, 2025, after the close of the U.S. capital markets on Wednesday, May 7, 2025. In …
Cytokinetics to Participate in May Investor Conferences
GlobeNewswire
·
April 30, 2025
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company is scheduled to participate in the following investor conferences in May: The Citizens Life Sciences Conference: …
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
GlobeNewswire
·
April 30, 2025
WARREN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that CD8 Technology Services LLC (“CD8”) has signed a letter of intent for a facility designed to support Tevogen Bio’s cell …
VOW ASA: Annual and Sustainability Report 2024
GlobeNewswire
·
April 30, 2025
Vow ASA has today published its Annual and Sustainability Report for 2024, as approved by the Board of Directors. The report, including the ESEF file, is enclosed and is also available on the company’s website: www.vowasa.com under Investor Relations: …
Gildan Activewear Reports on Shareholders’ Voting Results
GlobeNewswire
·
April 30, 2025
MONTRÉAL, April 30, 2025 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) today announced that the eight nominees proposed as directors in its management proxy circular dated March 18, 2025 were elected as …
Les Vêtements de Sport Gildan publie les résultats du vote des actionnaires
GlobeNewswire
·
April 30, 2025
MONTRÉAL, 30 avr. 2025 (GLOBE NEWSWIRE) -- Les Vêtements de Sport Gildan Inc. (TSX et NYSE : GIL) (« Gildan » ou la « Société ») a annoncé aujourd’hui que les huit candidats proposés comme administrateurs dans sa circulaire de sollicitation de procurations …